-
MiniDock MTB Test
MiniDock MTB Test detects Mycobacterium tuberculosis from sputum or tongue swabs, with results in as fast as 5 minutes. Tongue swab sampling enables testing for patients unable to expectorate sputum. It addresses major TB diagnostic challenges—sputum scarcity, biohazard risks, and cost—using RHAM technology to match PCR-level performance without complex lab setup.¥ 0.00More >
-
SARS-CoV-2/FIu A/Flu B
With the rise of respiratory illnesses like COVID-19, Flu A, and Flu B, efficient and accurate testing is vital. As of July 2024, SARS-CoV-2 has caused over 760 million cases worldwide, and seasonal flu affects millions each year. Quick, precise diagnosis is key to effective management. Traditional methods can be cumbersome for rapid, frequent testing.
This kit provides a streamlined solution for in vitro detection of SARS-CoV-2, Influenza A, and Influenza B RNA in nasal swab samples.¥ 0.00More >
-
HPV 16/18/45
HPV types 16, 18, and 45 are linked to various cancers, notably cervical cancer, with types 16 and 18 causing about 70% of cases. With over 600,000 new cervical cancer cases annually as of July 2024, early screening is crucial. Traditional methods may be slow, delaying follow-up and treatment.
This kit offers rapid detection of HPV types 16, 18, and 45 DNA in cervical and vulvovaginal swabs, aiding early diagnosis and cancer prevention.¥ 0.00More >
-
SARS-CoV-2
Traditional large testing equipment is often impractical for frequent, quick tests. Quick and accurate testing methods are essential for timely diagnosis and effective management of COVID-19 cases. Accurate COVID-19 diagnosis is crucial due to its global impact and high transmission rates.
This kit provides in vitro qualitative detection of the N gene and ORF1ab gene of SARS-CoV-2 in nasal swabs from suspected COVID-19 cases.¥ 0.00More >
-
Pluslife MiniDock MTB Test Receives ERPD Listing
MiniDock MTB Test has been listed under the Expert Review Panel for Diagnostics (ERPD).
2025-07-14
-
Pluslife Showcased Innovative Molecular Diagnostics at WHX Lagos & WHX Labs Lagos 2025
Pluslife showcased its innovative tuberculosis nucleic acid test platform at WHX Lagos 2025.
2025-06-05
-
Pluslife Showcases Diagnostic Innovation at WHA78 Side Event: Innovation in Financing and New Technologies to End TB
We remain committed to developing scalable, accessible diagnostic solutions that strengthen TB response efforts in high-burden settings.
2025-05-23
